Finance

Beta
Lists
7716:TYO
Nakanishi Inc
Â¥2,983.00
-2.20%
(-67.00) 1D
Jun 8, 2:41:21 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7716...
Open
Â¥2,949
High
Â¥3,015
Low
Â¥2,923
Mkt. cap
275.09B
Avg. vol.
249.53K
Volume
172.70K
Dividend
1.81%
Quarterly dividend
Â¥14
Ex-dividend date
Jun 29, 2026
P/E ratio
227.08
52-wk high
Â¥3,180
52-wk low
Â¥1,797
EPS
Â¥13
Shares outstanding
86.64M
No. of employees
2K
Open
Â¥2,949
High
Â¥3,015
Low
Â¥2,923
Mkt. cap
275.09B
Avg. vol.
249.53K
Volume
172.70K
Dividend
1.81%
Quarterly dividend
Â¥14
Ex-dividend date
Jun 29, 2026
P/E ratio
227.08
52-wk high
Â¥3,180
52-wk low
Â¥1,797
EPS
Â¥13
Shares outstanding
86.64M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to 7716 in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for 7716 in the last 3 months.
Highest
Current ¥2,983.00
Â¥3,879.82 (+30.06%)
Average
Â¥3,361.67 (+12.69%)
Lowest
Â¥2,487.06 (-16.63%)
News stories
From sources across the web
About Nakanishi Inc
CEO-
Employees2.2K
FoundedJun 1, 1981
Headquarters-
SectorMedical device
Websitejapan.nsk-dental.com
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
22.49B / 20.42B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.65B
19.56B
22.43B
22.49B
Cost of goods sold
8.62B
9.13B
9.91B
9.55B
Cost of revenue
8.62B
9.13B
9.91B
9.55B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.80B
7.48B
5.16B
8.26B
Operating expense
7.80B
7.48B
8.97B
8.26B
Total operating expenses
16.42B
16.61B
18.88B
17.81B
Operating income
4.23B
2.95B
3.55B
4.68B
Other non operating income
43.98M
86.60M
-176.68M
66.00M
EBT including unusual items
4.42B
4.00B
-7.77B
5.55B
EBT excluding unusual items
4.30B
4.02B
6.00B
5.55B
Income tax expense
1.35B
1.33B
804.67M
1.57B
Effective tax rate
30.55%
33.31%
-10.35%
28.25%
Other operating expenses
-
-
-
-
Net income
3.07B
2.67B
-8.58B
3.98B
Net profit margin
14.87%
13.65%
-38.25%
17.70%
Earnings per share
-
-
-
-
Interest and investment income
229.56M
320.25M
724.68M
344.00M
Interest expense
-39.22M
-49.77M
-73.40M
-71.00M
Net interest expenses
190.34M
270.48M
651.28M
273.00M
Depreciation and amortization charges
-
-
2.34B
-
EBITDA
5.63B
-
5.00B
6.13B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer